Neurodevelopmental Outcomes for Individuals With Congenital Heart Disease: Updates in Neuroprotection, Risk-Stratification, Evaluation, and Management: A Scientific Statement From the American Heart Association
Erica Sood(Thomas Jefferson University), Bradley S. Marino(Cleveland Clinic Lerner College of Medicine), Richard A. Jonas(Children's National), Shabnam Peyvandi(University of California, San Francisco), Keila N. Lopez, Julia S. Anixt, Jane W. Newburger(Oregon Health & Science University), Amy Jo Lisanti(Children's Hospital of Philadelphia), Jamie L. Jackson(Nationwide Children's Hospital), Adam R. Cassidy(Mayo Clinic in Florida)
Cited by 176
Related Papers
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association
|Circulation|2017|3.7k
Prevention of Infective Endocarditis
|Circulation|2007|2.8k
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease
|Circulation|2004|1.9k
Prevention of bacterial endocarditis. Recommendations by the American Heart Association
|Journal of Cardiothoracic and Vascular Anesthesia|1997|1.3k
A Single Intravenous Infusion of Gamma Globulin as Compared with Four Infusions in the Treatment of Acute Kawasaki Syndrome
|New England Journal of Medicine|1991|1.2k